United Therapeutics Corporation

Historical 13F Holders

Symbol
UTHR
CUSIP
91307C102
All holders as of
Q1 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q1 894 41.1 M $24.3 B
2025 Q4 864 41.8 M $20.3 B
2025 Q3 758 41.2 M $17.3 B
2025 Q2 701 44.1 M $12.7 B
2025 Q1 697 45.0 M $13.9 B
2024 Q4 705 44.3 M $15.6 B
2024 Q3 655 44.2 M $15.8 B
2024 Q2 602 47.1 M $15.0 B
2024 Q1 559 46.6 M $10.7 B
2023 Q4 558 45.5 M $10.0 B
2023 Q3 537 44.6 M $10.1 B
2023 Q2 502 45.1 M $9.94 B
2023 Q1 528 45.8 M $10.1 B
2022 Q4 535 46.6 M $13.0 B
2022 Q3 483 45.8 M $9.58 B
2022 Q2 492 44.2 M $10.4 B
2022 Q1 450 44.2 M $7.92 B
2021 Q4 440 43.3 M $9.37 B
2021 Q3 445 44.3 M $8.17 B
2021 Q2 421 44.2 M $7.93 B
2021 Q1 416 43.7 M $7.32 B
2020 Q4 386 44.2 M $6.72 B
2020 Q3 354 42.2 M $4.27 B
2020 Q2 376 42.6 M $5.15 B
2020 Q1 329 43.2 M $4.09 B
2019 Q4 344 41.9 M $3.69 B
2019 Q3 331 41.8 M $3.33 B
2019 Q2 356 42.2 M $3.29 B
2019 Q1 402 42.9 M $5.02 B
2018 Q4 380 44.1 M $4.78 B
2018 Q3 390 44.1 M $5.62 B
2018 Q2 397 42.9 M $4.85 B
2018 Q1 396 43.8 M $4.91 B
2017 Q4 422 44.6 M $6.56 B
2017 Q3 403 43.7 M $5.13 B
2017 Q2 399 46.3 M $6.01 B
2017 Q1 439 49.8 M $6.75 B
2016 Q4 435 48.0 M $6.88 B
2016 Q3 423 48.8 M $5.75 B
2016 Q2 413 49.6 M $5.25 B
2016 Q1 424 51.2 M $5.70 B
2015 Q4 415 51.6 M $8.08 B
2015 Q3 392 51.0 M $6.70 B
2015 Q2 409 51.0 M $8.87 B
2015 Q1 387 52.4 M $9.03 B
2014 Q4 351 51.6 M $6.69 B
2014 Q3 340 53.1 M $9.17 B
2014 Q2 317 53.6 M $4.75 B
2014 Q1 328 67.6 M $7.83 B